Andrew Kenneth William Powell's Net Worth
$1.17 Million
Who is Andrew Kenneth William Powell?
Andrew Kenneth William Powell has an estimated net worth of $1.17 Million. This is based on reported shares across multiple companies, which include Aclaris Therapeutics, Inc., LANDEC CORP \CA\, Synthorx, Inc., Silverback Therapeutics, Inc., MEDIVATION, INC., CORNERSTONE THERAPEUTICS INC, INTERMUNE INC, COLLAGENEX PHARMACEUTICALS INC, and IMCLONE SYSTEMS INC.
SEC CIK
Andrew Kenneth William Powell's CIK is 0001304113
Past Insider Trading and Trends
2020 was Andrew Kenneth William Powell's most active year for acquiring shares with 8 total transactions. Andrew Kenneth William Powell's most active month to acquire stocks was the month of May. 2014 was Andrew Kenneth William Powell's most active year for disposing of shares, totalling 13 transactions. Andrew Kenneth William Powell's most active month to dispose stocks was the month of August. 2014 saw Andrew Kenneth William Powell paying a total of $128,217.32 for 35,027 shares, this is the most they've acquired in one year. In 2020 Andrew Kenneth William Powell cashed out on 57,813 shares for a total of $1,814,038.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.15% | 4.66K |
—
|
—
| 33.52K |
Jun 1
| |||
Form 4
| +100.95% | 14.5K |
$1.24 | $17,955.00 | 28.86K |
Mar 1 - Mar 4
| |||
Form 4
| +45.73% | 4.51K |
—
|
—
| 14.36K |
Jun 1 - Jun 2
| |||
Form 4
| -28.87% | -4.00K |
—
|
—
| 9.86K |
Nov 8
| |||
Form 4
| +23.61% | 2.65K |
—
|
—
| 13.86K |
May 16 - Jun 3
| |||
Form 4
| -32.92% | -5.50K |
—
|
—
| 11.21K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +78.21% | 7.33K |
—
|
—
| 16.71K |
Jun 4 - Jun 6
| |||
Form 4
| +1,775.20% | 8.88K |
—
|
—
| 9.38K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 500 |
$19.12 | $9,560.00 | 500 |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LANDEC CORP \CA\ (LFCR) Snapshot price: $5.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.57% | 7.06K |
$9.50 | $67,060.50 | 27.48K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +68.53% | 8.3K |
$11.64 | $96,646.92 | 20.42K |
Jun 1
| |||
Form 4
| +22.19% | 2.2K |
$10.36 | $22,792.00 | 12.12K |
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +153.26% | 6K |
$10.99 | $65,940.00 | 9.91K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
| +291.50% | 2.92K |
$9.91 | $28,887.65 | 3.92K |
May 28 - May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
| +110.53% | 525 |
$11.62 | $6,100.50 | 1K |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Synthorx, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Silverback Therapeutics, Inc. (SPRY) Snapshot price: $11.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEDIVATION, INC. No price found
SVP, General Counsel & Crp Sec
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -28.52K |
—
|
—
|
0
|
Sep 28
| |||
Form 4
| -8.29% | -2.58K |
$60.42 | -$155,762.76 | 28.52K |
Jun 6
| |||
Form 4/A
| +45.08% | 9.3K |
—
|
—
| 29.93K |
Feb 18
| |||
Form 4
| +32.12% | 9.3K |
—
|
—
| 38.25K |
Feb 18 - Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +10,215.00% | 10.21K |
—
|
—
| 10.31K |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||